• WE ARE
    • We Are Early Phase
    • In a Nutshell
    • Our History
    • Facilities
    • Values
    • Management
    • Quality Principles
    • How we work
    • Partner
  • EARLY PHASE
    • First-in-Human
    • Interaction
    • Inhalation
    • Infusion & injection
    • Cardiac safety
    • PK/PD
    • Proof of Concept
    • Biosimilars
    • Vaccines
    • Bioequivalence
  • SERVICES
    • Development Consulting
    • Regulatory Consulting
    • Medical Writing
    • Data Management
    • Statistics
    • Multi-Site Service
    • Bioanalytics
  • PATIENT TRIALS
    • Diabetes
    • Obesity and Metabolism
    • Hypertension, Lipids, Inflammation, Endothelial Dysfunction
    • NAFLD/NASH
    • Dermatology
    • Endometriosis
    • Polycystic Ovary Syndrome
    • Medical Device Studies
    • Hemostaseology
    • Hepatology
    • Renal Impairment
    • Your individual request
  • SCIENCE
    • Our approach
    • Publications
  • CAREER
  • NEWS
  • WE ARE
    • We Are Early Phase
    • In a Nutshell
    • Our History
    • Facilities
    • Values
    • Management
    • Quality Principles
    • How we work
    • Partner
  • EARLY PHASE
    • First-in-Human
    • Interaction
    • Inhalation
    • Infusion & injection
    • Cardiac safety
    • PK/PD
    • Proof of Concept
    • Biosimilars
    • Vaccines
    • Bioequivalence
  • SERVICES
    • Development Consulting
    • Regulatory Consulting
    • Medical Writing
    • Data Management
    • Statistics
    • Multi-Site Service
    • Bioanalytics
  • PATIENT TRIALS
    • Diabetes
    • Obesity and Metabolism
    • Hypertension, Lipids, Inflammation, Endothelial Dysfunction
    • NAFLD/NASH
    • Dermatology
    • Endometriosis
    • Polycystic Ovary Syndrome
    • Medical Device Studies
    • Hemostaseology
    • Hepatology
    • Renal Impairment
    • Your individual request
  • SCIENCE
    • Our approach
    • Publications
  • CAREER
  • NEWS

Standardized modulation of the injection site allows for insulin dose reduction without deterioration of metabolic control.

Science 21. November 2022
ShareTwitterFacebookXingLinkedin
First published in Current Medical Research and Opinion on 2014 Oct.Curr Med Res Opin. 2014 Oct;30(10):2001-8. doi: 10.1185/03007995.2014.933098. Epub 2014...
Read Article

Vildagliptin, a DPP-4 inhibitor for the twice-daily treatment of type 2 diabetes mellitus with or without metformin.

Science 21. November 2022
ShareTwitterFacebookXingLinkedin
First published in Expert Opinion on Pharmacotherapy on 2014 Jun.Expert Opin Pharmacother. 2014 Jun;15(9):1299-313. doi: 10.1517/14656566.2014.920009 Authors: Forst T, Bramlage...
Read Article

Dose-finding results in an adaptive, seamless, randomized trial of once-weekly dulaglutide combined with metformin in type 2 diabetes patients (AWARD-5).

Science 21. November 2022
ShareTwitterFacebookXingLinkedin
First published in Diabetes, Obesity and Metabolism on 2014 Aug. Diabetes Obes Metab. 2014 Aug;16(8):748-56. doi: 10.1111/dom.12305. Epub 2014 May...
Read Article

Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone.

Science 21. November 2022
ShareTwitterFacebookXingLinkedin
First published in Diabetes, Obesity and Metabolism on 2014 May. Diabetes Obes Metab. 2014 May;16(5):467-77. doi: 10.1111/dom.12273. Epub 2014 Mar...
Read Article

Effect of linagliptin compared with glimepiride on postprandial glucose metabolism, islet cell function and vascular function parameters in patients with type 2 diabetes mellitus receiving ongoing metformin treatment.

Science 21. November 2022
ShareTwitterFacebookXingLinkedin
First published in Diabetes Metabolism Research and Reviews on 2014 Oct. Diabetes Metab Res Rev. 2014 Oct;30(7):582-9. doi: 10.1002/dmrr.2525 Authors:...
Read Article

The Barmer study: impact of standardized warming of the injection site to enhance insulin absorption and reduce prandial insulin requirements and hypoglycemia in obese patients with diabetes mellitus.

Science 21. November 2022
ShareTwitterFacebookXingLinkedin
First published in Current Medical Research and Opinion on 2014 May. Curr Med Res Opin. 2014 May;30(5):753-60. doi: 10.1185/03007995.2014.880049. Epub...
Read Article

Pharmacological profile, efficacy and safety of lixisenatide in type 2 diabetes mellitus.

Science 21. November 2022
ShareTwitterFacebookXingLinkedin
First published in Expert Opinion on Pharmacotherapy on 2013 Nov. Expert Opin Pharmacother. 2013 Nov;14(16):2281-96. doi: 10.1517/14656566.2013.838559. Epub 2013 Oct...
Read Article

Effects of insulin glargine versus metformin on glycemic variability, microvascular and beta-cell function in early type 2 diabetes.

Science 21. November 2022
ShareTwitterFacebookXingLinkedin
First published in Acta Diabetologica in 2013 Aug.Acta Diabetol. 2013 Aug;50(4):587-95. doi: 10.1007/s00592-012-0451-9. Epub 2013 Feb 21. Authors: Pistrosch F,...
Read Article

High-sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: effects of insulin-sensitizing treatment with pioglitazone.

Science 10. November 2022
ShareTwitterFacebookXingLinkedin
First published in Journal of Diabetes Science and Technology on 2010 May.J Diabetes Sci Technol. 2010 May 1;4(3):706-16 Authors: Pfützner...
Read Article

Pilot study for assessment of optimal frequency for changing catheters in insulin pump therapy-trouble starts on day 3.

Science 10. November 2022
ShareTwitterFacebookXingLinkedin
First published in Journal of Diabetes Science and Technology on 2010 Jul.J Diabetes Sci Technol. 2010 Jul 1;4(4):976-82 Authors: Schmid...
Read Article

Beitragsnavigation

Page 1 Page 2 Page 3 >
QUICK LINKS
  • WE ARE
    • In a Nutshell
    • Our History
    • Facilities
    • Values
    • MANAGEMENT
  • EARLY PHASE
    • First-in-human
    • Cardiac safety
    • Infusion & injection
    • Inhalation
    • Pharmacology
    • Interaction
    • Consultancy
    • Medical Writing
    • Data Management
.
  • PATIENT TRIALS
    • Cardiometabolics
    • Dermatology
    • Women‘s Health
    • Hemostaseology
    • Hepatology
    • Pulmology
    • Renal Impairment
    • Vaccines
    • Your individual request
  • SCIENCE
  • WORK WITH US
EXPERTISE
  • Consultancy
  • Medical Writing
  • Early Phase
FACILITIES
  • Berlin
  • Kiel
  • Mannheim
  • Wuppertal
FÜR PROBANDEN
  • ÜBER STUDIEN
  • AN STUDIEN TEILNEHMEN
  • www.probandeninfo.de
LEGAL
  • PRIVACY
  • IMPRINT
  • DISCLAIMER
  • —
  • Career
    • CURRENT JOB
    • OPPORTUNITIES
Copyright © 2023 CRS. Experts. Early Phase. All rights reserved.